Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
FEBS Letters|November 26, 2015
MgcRacGAP inhibition stimulates JAK-dependent STAT3 activityArjan J van Adrichem, Krister Wennerberg
Plos One|April 2, 2020
Identification of novel regulators of STAT3 activityElina Parri, Heikki Kuusanmäki, Arjan J van Adrichem, et al.
Chemical Communications (Cambridge, England)|March 3, 2018
Toward universal protein post-translational modification detection in high throughput formatHarri Härmä, Natalia Tong-Ochoa, Arjan J van Adrichem, et al.
Analytical Chemistry|March 21, 2017
High-Throughput Dual Screening Method for Ras Activities and InhibitorsKari Kopra, Arjan J van Adrichem, Outi M H Salo-Ahen, et al.
Combinatorial Chemistry & High Throughput Screening|December 6, 2014
Discovery of MINC1, a GTPase-activating protein small molecule inhibitor, targeting MgcRacGAPArjan J van Adrichem, Annika Fagerholm, Laura Turunen, et al.
Analytical and Bioanalytical Chemistry|April 25, 2014
A homogeneous quenching resonance energy transfer assay for the kinetic analysis of the GTPase nucleotide exchange reactionKari Kopra, Alessio Ligabue, Qi Wang, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 1, 2021
Rac1/pSTAT3 expression: A pharmacodynamic marker panel as a first step toward optimization of thiopurine therapy in inflammatory bowel disease patientsDebbie S Deben, Arjan J van Adrichem, Roosmarie Drent, et al.
Scientific Reports|September 22, 2022
A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patientsDebbie S Deben, Rob H Creemers, Arjan J van Adrichem, et al.
Oncotarget|December 13, 2017
Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signalingHeikki Kuusanmäki, Olli Dufva, Elina Parri, et al.
Clinical Chemistry and Laboratory Medicine|February 8, 2021
Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzerRemy J H Martens, Arjan J van Adrichem, Nadine J A Mattheij, et al.
Pageof 2